# Stryker (SYK) — Earnings

SYK · NYSE · Stock

Canonical page: https://www.lighthorse.io/tickers/syk/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q2 2026 |
| Period end | Jun 30, 2026 |
| EPS actual | $3.69 |
| EPS estimate | $3.49 |
| EPS surprise | +5.78% |
| Revenue surprise | +0.15% |
| Revenue | $6.6B |
| Revenue estimate | $6.6B |
| Reported | Jul 30, 2026 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/310764/000031076426000050/syk-20260630.htm) |
| Earnings call | [Transcript](http://o.thsi.cn/dc-d-stock-america.teleconference/f5681a2b-ad2b-d1a2-48eb-8710629487e5.html) |

Stryker reported Q2 2026 results on July 30, 2026. Earnings per share came in at $3.69, ahead of the $3.49 estimate by 5.78%. Revenue was $6.6 billion, 0.15% above the consensus. Compared with Q2 2025, EPS rose about 18% from $3.13 and revenue rose about 10% from $6.0 billion.

The longer record shows steady growth. Annual EPS rose each year, from $9.34 in 2022 to $10.60 in 2023, $12.19 in 2024 and $13.63 in 2025. The first half of 2026 adds up to $6.29, about 5% more than a year earlier. Q4 is the largest quarter of each year in the table, and Q4 2025 set the highs here at $4.47 per share and $7.2 billion in revenue. Over the last 20 quarters, Stryker beat the EPS estimate 15 times. Its largest miss was Q1 2026, at 12.77% below, when EPS of $2.60 came in under the $2.84 of a year earlier.

Stryker reported Q3 between October 28 and November 2 in each of the past five years. That points to late October or early November 2026 for the next report. It will show whether the year-over-year growth in Q2 carries into the third quarter.

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q2 2026 | Jul 30, 2026 | $3.49 | $3.69 | 5.78% | $6.6B | $6.6B |
| Q1 2026 | Apr 30, 2026 | $2.98 | $2.60 | -12.77% | $6.3B | $6.0B |
| Q4 2025 | Jan 29, 2026 | $4.40 | $4.47 | 1.68% | $7.1B | $7.2B |
| Q3 2025 | Oct 30, 2025 | $3.13 | $3.19 | 1.82% | $6.0B | $6.1B |
| Q2 2025 | Jul 31, 2025 | $3.07 | $3.13 | 2.00% | $5.9B | $6.0B |
| Q1 2025 | May 1, 2025 | $2.71 | $2.84 | 4.63% | $5.7B | $5.9B |
| Q4 2024 | Jan 28, 2025 | $3.87 | $4.01 | 3.57% | $6.4B | $6.4B |
| Q3 2024 | Oct 29, 2024 | $2.77 | $2.87 | 3.52% | $5.4B | $5.5B |
| Q2 2024 | Jul 30, 2024 | $2.79 | $2.81 | 0.66% | $5.4B | $5.4B |
| Q1 2024 | Apr 30, 2024 | $2.36 | $2.50 | 6.13% | $5.1B | $5.2B |
| Q4 2023 | Jan 30, 2024 | $3.27 | $3.46 | 5.85% | $5.6B | $5.8B |
| Q3 2023 | Nov 2, 2023 | $2.43 | $2.46 | 1.04% | $4.9B | $4.9B |
| Q2 2023 | Aug 3, 2023 | $2.38 | $2.54 | 6.69% | $4.8B | $5.0B |
| Q1 2023 | May 1, 2023 | $2.00 | $2.14 | 6.88% | $4.6B | $4.8B |
| Q4 2022 | Jan 31, 2023 | $2.84 | $3.00 | 5.78% | $5.0B | $5.2B |
| Q3 2022 | Oct 31, 2022 | $2.20 | $2.12 | -3.59% | $4.5B | $4.5B |
| Q2 2022 | Jul 26, 2022 | $2.27 | $2.25 | -1.06% | $4.5B | $4.5B |
| Q1 2022 | Apr 28, 2022 | $1.95 | $1.97 | 1.26% | $4.2B | $4.3B |
| Q4 2021 | Jan 27, 2022 | $2.72 | $2.71 | -0.46% | $4.6B | $4.7B |
| Q3 2021 | Oct 28, 2021 | $2.28 | $2.20 | -3.36% | $4.2B | $4.2B |

## Frequently Asked Questions

### When did Stryker (SYK) last report earnings?

Stryker last reported on Jul 30, 2026, covering fiscal Q2 2026.

### Did SYK beat earnings estimates?

Yes. Stryker reported EPS of $3.69 for Q2 2026 against a $3.49 estimate — a 5.78% beat.

### How much revenue did SYK report last quarter?

Stryker reported $6.6B in revenue for Q2 2026, against a consensus estimate of $6.6B.

## Similar Stocks

- [CAH](https://www.lighthorse.io/tickers/cah) — Cardinal Health, Inc. Common Stock
- [DVA](https://www.lighthorse.io/tickers/dva) — DaVita Inc. Common Stock
- [COR](https://www.lighthorse.io/tickers/cor) — Cencora, Inc. Common Stock
- [ZBH](https://www.lighthorse.io/tickers/zbh) — Zimmer Biomet Holdings, Inc. Common Stock
- [MDT](https://www.lighthorse.io/tickers/mdt) — Medtronic plc. Ordinary Shares
- [ISRG](https://www.lighthorse.io/tickers/isrg) — Intuitive Surgical, Inc. - Common Stock

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).